Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery
Journal: Nature Biotechnology
Published: 2019-11-11
DOI: 10.1038/s41587-019-0296-7
Affiliations: 8
Go to article